2؉ for growth at 37 C. They harbor closely related plasmids of about 70 kb that are essential for virulence. At 37 C and in the absence of Ca 2؉ ions, these plasmids cause a decrease in growth rate and the release of large amounts of proteins called Yops. Here we describe the virG gene of Yersinia enterocolitica; virG is located just upstream of the virF gene, which encodes the transcriptional activator of some plasmid virulence factors. Analysis of the VirG amino acid sequence suggested that virG encodes a lipoprotein, which was confirmed by [ 3 H]palmitate labeling of VirG-PhoA fusion proteins. A nonpolar virG mutant was constructed and found to be Ca 2؉ independent for growth at 37 C but to still secrete Yops. This phenotype was complemented by the introduction of a plasmid harboring an intact virG gene. VirG was found to be homologous to ExsB, a protein encoded by a Pseudomonas aeruginosa gene located in the locus controlling exoenzyme S synthesis. Interestingly, the exsA gene, located just downstream of exsB, is also homologous to virF.
Pathogenic bacteria of the genus Yersinia (Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica) cause disease in rodents and humans, with symptoms ranging from enteritis to septicemia and death, essentially by invading the host tissues. They harbor closely related plasmids of about 70 kb that are essential for virulence and hence are called pYV (for Yersinia virulence). At 37ЊC and in a medium deprived of Ca 2ϩ ions, the pYV plasmid directs secretion of about 10 proteins called Yops. In Y. enterocolitica these are YopB, -D, -E, -H, -M, -N, -O, -P, and -Q and LcrV, the protective antigen described in the mid-1950s by Burrows and Bacon (6) . For reviews, see references 8, 9, 16, 53, and 54. Yop secretion is achieved by a type III secretion pathway which is encoded by three loci on the pYV plasmid called virA, virB, and virC. The virC locus contains the 12 genes yscA to yscL, as well as yscM (also known as lcrQ) (33, 47) . The virB locus contains the eight genes yscN to yscU (2, 3, 15, 61) , and locus virA contains lcrD (40) . Apart from the secretion apparatus itself, secretion of YopE, YopH, and YopD requires individual cytosolic chaperones called SycE, SycH, and SycD, respectively (58, 59) . By binding their cognate Yop, these chaperones either protect the intrabacterial form against folding or association or act as a pilot directing the associated Yop to the secretion machinery.
Yop synthesis and secretion are thermoregulated at the transcriptional level. Some yop genes are scattered around the pYV plasmid, while others, like lcrV, yopB, and yopD, form an operon (4, 36, 44) . The yop genes and operons, as well as some of the ysc genes, form a regulon under the positive control of VirF, a transcriptional activator of the AraC family (12, 23, 29, 60) and under the negative control of YmoA, a histone-like global regulator (11, 46) . Transcription of the virF gene is thermoinduced, which contributes to the thermoregulation of Yop secretion (29) . Yop secretion is also regulated by Ca 2ϩ : transcription of the yop genes is reduced in the presence of millimolar concentrations of Ca 2ϩ (13, 14, 18, 44) . It is generally believed that this regulation is of the negative type (17) , but no classical repressor has been identified so far. Besides these two regulatory circuits, the secretion apparatus itself exerts a feedback regulatory effect on transcription of the yop genes. It has been observed for a long time that yop transcription is reduced when export is compromised (2, 3, 14, 15, 61) . Recent data suggest that LcrQ (YscM in Y. enterocolitica) could be an element of this third regulatory circuit (47) , but this remains to be demonstrated. Ca 2ϩ regulation and feedback inhibition might be related phenomena: if Ca 2ϩ prevents the assembly of the secretion machinery in the membranes or prevents secretion itself, then feedback inhibition will lead to the observed reduction of transcription. pYV ϩ yersiniae are unable to grow on oxalated media at 37ЊC (22) . Hence, at 37ЊC in the absence of Ca 2ϩ , they not only secrete Yops but also restrict their growth; they are therefore called Ca 2ϩ dependent. Like the exact role of Ca 2ϩ , the link between Yop secretion and growth restriction remains elusive. Mutants affected in the virF gene as well as those with nonpolar mutations in either the virA or virB operon are, as expected, unable to secrete Yops, and they grow well at 37ЊC irrespective of the presence or absence of Ca 2ϩ . They are thus Ca 2ϩ independent (CI). A nonpolar lcrV mutant was also reported to be CI and unable to secrete Yops, supporting the idea that LcrV is a regulatory protein (4, 43) .
Mutants with mutations in lcrE (yopN) secrete all of the Yops except YopN at 37ЊC, even in the presence of Ca 2ϩ ions. Hence, they are ''Ca 2ϩ blind'' for Yop secretion and do not grow at 37ЊC irrespective of the presence or absence of Ca 2ϩ (17, 66) . A nonpolar mutation affecting another secreted protein, LcrG, also leads to the same Ca 2ϩ -blind phenotype (51) . The phenotypes of these two classes of mutants (CI and Ca 2ϩ blind) support the hypothesis that growth restriction and Yop production and secretion are linked phenomena.
In the present paper we describe virG, a new pYV gene involved in growth restriction. We characterize the gene product and analyze the phenotype of the mutant.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Y. enterocolitica W22703 (nalidixic acid resistant) is a restriction mutant (Res Ϫ Mod ϩ ) of the O:9 serotype strain W227 (10) . Y. enterocolitica KNG22703 is a mutant of strain W22703 in which the bla gene encoding ␤-lactamase A was replaced by the luxAB genes (24) . Escherichia coli LK111, DH5␣ pir ϩ , and XL1-blue (Stratagene, La Jolla, Calif.) were used for standard genetic manipulations. E. coli Sm10 pir ϩ was used to deliver mobilizable plasmids in Y. enterocolitica (35) . E. coli CJ236 (dut ung) was used for site-directed mutagenesis (27) . The strains were routinely grown in tryptic soy broth (Oxoid, Basingstoke, England) and plated on tryptic soy agar (TSA) (Oxoid), which sometimes was supplemented with 20 mM MgCl 2 and 20 mM Na-oxalate (MOX). For induction of the yop regulon, Y. enterocolitica was grown in brain heart infusion (Difco, Detroit, Mich.) supplemented with 4 mg of glucose ml Ϫ1 , 20 mM MgCl 2 , and 20 mM Na-oxalate (BHI-OX). M9 medium (MgSO 4 , 1 mM; CaCl 2 , 100 M; NaCl, 86 mM; Na 2 HPO 4 , 420 mM; KH 2 PO 4 , 220 mM; NH 4 Cl, 190 mM; and glucose, 4 mg ml
Ϫ1
) was used for the labeling of VirG. Antibiotics were used at the following concentrations: ampicillin, 300 g ml Ϫ1 ; kanamycin, 50 g ml
; tetracycline, 10 g ml
; nalidixic acid, 35 g ml
; and streptomycin, 30 g ml Ϫ1 . The plasmids used are listed in Table 1 . Molecular cloning and sequencing procedures. Plasmid DNA purification, DNA restriction and separation by gel electrophoresis, transfer and hybridization, ligation, and transformation of E. coli strains were performed according to standard methods (49) . Nucleotide sequences of virG and the surrounding region were determined by the dideoxy chain termination procedure with single-or double-stranded DNA (50) . Both DNA strands were completely sequenced on plasmids pGCS68B and pRS7.
SDS-PAGE and immunoblotting. Electrophoresis in 10 or 14% polyacrylamide gels in the presence of sodium dodecyl sulfate (SDS-PAGE) was performed as described by Laemmli (28) . After electrophoresis, proteins were either stained with Coomassie brilliant blue, visualized by autoradiography, or transferred by electroblotting to a nitrocellulose membrane (56) . Immunoblotting procedures were carried out with rat monoclonal antibody 6G1 (anti-YopE), 13A4 (anti-YopD), 7C1 (anti-LcrV) (5), or a rabbit polyclonal serum raised against E. coli alkaline phosphatase (kindly provided by Bruno Dupuy, Institut Pasteur, Paris, France).
Induction of the yop regulon and analysis of Yops and Ca 2؉ dependency. Yops were prepared and analyzed by SDS-PAGE and Western blotting (immunoblotting) as described by Cornelis et al. (14) and Sory and Cornelis (52) . For the analysis of the whole-cell protein extract, the equivalent of 5 ϫ 10 8 bacteria, induced for Yop synthesis and secretion, were subjected to SDS-14% PAGE. The Ca 2ϩ requirement for growth at 37ЊC was monitored by plating the bacteria in parallel on TSA supplemented with 5 mM CaCl 2 and on MOX agar at 37ЊC.
Identification of the virG gene product. Specific labeling of VirG was achieved in E. coli LK111 containing pGP1-2 and either pRS7, pRS7A, or pRS7B by using the T7 expression system (55) (see Fig. 3 ). For more details, see reference 2.
Sequence analysis. Identity scores between proteins were calculated by using the FastA program, based on the method of Pearson and Lipman (39) , with a ktuple value of 1. The alignment was made by using the BESTFIT program available in the Genetics Computer Group sequence analysis software package (University of Wisconsin, Madison). The isoelectric point was calculated with the same program. The signal sequence was researched by using the SIGSEQ program (41), which is based on the rules of Von Heijne (57) . Engineering of a virG mutant. The virG gene was inactivated on the pYV plasmid by allelic exchange. First, plasmid pRS2 was constructed by cloning the 2,400-bp PstI-ScaI fragment of pGCS68A ( Fig. 1; Table 1 ) into the SmaI-PstI sites of pRS1 (pRS1 was obtained by destruction of the EcoRI restriction site of the vector pBC19R). We then replaced the 210-bp EcoRI-BstEII DNA fragment (from nucleotide 343 to 553) (Fig. 2 ) of pRS2 (after filling in the end) with an 850-bp SmaI DNA fragment containing the aphA-3 gene from pUC18K (conferring kanamycin resistance) (31) . The resultant plasmid was called pRS3 (Fig.  1) . In this construction, introduction of the aphA-3 cassette induces an early stop in virG translation and directs in-frame translation of the remaining 3Ј end of the mutated gene, avoiding putative polar effects on the transcription of the virF gene. Plasmid pRS5 was constructed by inserting the 2,460-bp PvuII fragment of pRS3 into the SmaI site of the suicide vector pKNG101 (24) (Fig. 1) . Finally, plasmid pRS5 was transferred to Y. enterocolitica KNG22703 by conjugal mating, and transconjugants were selected on plates that contained nalidixic acid and kanamycin. Clones in which a double recombinational event had exchanged the wild-type virG gene with the mutated copy carried by pRS5 were identified by their sensitivity to streptomycin. The structure of the resultant pYV plasmid carrying the virG mutation was confirmed by Southern analysis, and the corresponding pYV plasmid was designated pRS227.
TnphoA mutagenesis. For TnphoA mutagenesis, the target plasmid pRS7 carrying the virG gene ( Fig. 1 ) was first introduced in E. coli CC102FЈ containing TnphoA integrated in the chromosome. Five colonies were separately inoculated in 1 ml of tryptic soy broth. After 1 h of incubation at 37ЊC, 9 ml of the same medium containing 100 g of ampicilin ml
Ϫ1 and 400 g of kanamycin ml
was added and further incubated overnight. Plasmid DNA was extracted and used to transform E. coli KS272 (⌬phoA). In-frame fusions of the transposon in pRS7 were identified on plates containing XP (5-bromo-4-chloro-3-indolylphosphate), the chromogenic substrate of alkaline phosphatase, at a final concentration of 40 g ml Ϫ1 . TnphoA insertion sites were localized by DNA sequencing with oligonucleotide MIPA 178 (2) .
Alkaline phosphatase assay. Alkaline phosphatase activity was assayed by using the substrate p-nitrophenylphosphate as described by Manoil and Beckwith (30) . The activity was expressed in units of optical density at 420 nm (10 Ϫ3 ) per minute per 1.6 ϫ 10 9 bacteria (34).
In vivo labeling with [
3 H]palmitate. Yersinia strains were inoculated to an optical density at 600 nm of 0.1 in 5 ml of BHI-OX. After 2 h of incubation at room temperature with shaking, 250 Ci of [9,10- 3 H]palmitic acid (30 Ci mmol Ϫ1 ) (Dupont-NEN, Brussels, Belgium) was added to the culture, and bacteria were further incubated for 4 h at 37ЊC. Proteins were analyzed by SDS-PAGE and autoradiography. Oligonucleotide-directed mutagenesis. Site-directed mutagenesis of virG was performed according to the method of Kunkel et al. (27) . Oligonucleotide MIPA 197 (5Ј 707-GATACCTAAAACTAGCTATCCAAATTGC-734 3Ј) contained mismatches at positions 719, 720, and 722 (TAGC instead of ATGT), thereby changing cysteine 121 to serine (C121S) (Fig. 2) . In oligonucleotide MIPA 198 (5Ј 716-AACATGTTATCCGAATTCCCAGTCACCTAA-745 3Ј), nucleotides A at position 728 and G at position 733 were replaced by G and C, respectively, which introduced an EcoRI site (used for checking the mutation) and changed cysteine 125 to serine (C125S) (Fig. 2) . To generate these mutations, the dut ung E. coli CJ236 strain was transformed with plasmid pRS7 (Fig. 1) . A uracilcontaining single-stranded pRS7 DNA was isolated and annealed to the phosphorylated oligonucleotides MIPA 197 and MIPA 198; the second DNA strand was synthesized and circularized by using T4 DNA polymerase and T4 DNA ligase. The resulting double-stranded DNA was used to transform E. coli XL1-blue. Sequence analysis of plasmids pRS7A and pRS7B confirmed the expected replacements. The mutated virG gene was verified by T7 expression with the T7 RNA polymerase system (data not shown). The 235-bp BstEII-ClaI DNA fragment of pRS6 was then replaced by the corresponding mutagenized fragments from pRS7A and pRS7B, giving rise to plasmids pRS6A and pRS6B, respectively (Fig. 1) . Finally, these plasmids were controlled by restriction and sequence analysis and then used for the trans-complementation experiments with the virG mutant (see Results).
Nucleotide sequence accession number. The sequence of virG (Fig. 2 ) has been submitted to the GenBank nucleotide sequence data library under accession number U21297.
RESULTS
Nucleotide sequence of the region upstream of virF. We analyzed the 0.8-kb region of the pYV plasmid which is localized between yscU, the last gene of the virB operon (2), and virF, the activator for thermal induction (12) . The yscU gene is followed by a 400-bp sequence containing stop codons in all three reading frames and a 40-nucleotide perfect palindrome (underlined in Fig. 2) (2) . At 176 bp downstream from this putative strong terminator, we detected an open reading frame extending to nucleotide 753, preceded by a fairly good ribosome binding site (AGGGGAGA). Translation of this open reading frame, called virG, would result in a polypeptide of 131 amino acid residues with a predicted molecular mass of 14,689 Da and a calculated isoelectric point of 11.06. The virG gene is followed by a 7-bp inverted repeat encompassing the stop codon.
Identification of the virG gene product. Specific labeling of VirG was achieved in E. coli by using the T7 expression system (55). Plasmid pRS7 (Fig. 1) containing virG mediated the production of a major protein of about 15 kDa, which is in good agreement with the predicted molecular mass of the virG gene product (Fig. 3, lane 2) .
Localization of VirG. The N-terminal sequence of the virG gene product contains one basic amino acid residue followed by a stretch of noncharged and hydrophobic residues, which are characteristic features of a signal sequence (48) , suggesting that VirG could be a protein exported by the general export pathway. To confirm this hypothesis, we carried out TnphoA mutagenesis (30) . Plasmid pRS7, expressing virG from the lac promoter, was mutagenized with TnphoA in E. coli (see Materials and Methods). The insertion sites of TnphoA in three mutants (pRS8, -9, and -11) were determined at the nucleotide level, and the hybrid VirG-PhoA proteins were analyzed by Western blotting with an antiserum directed against E. coli alkaline phosphatase (Fig. 4B) . The three hybrid proteins had sizes of about 53 kDa, values which were in agreement with the determined insertion sites. We then assayed the alkaline phosphatase activity in extracts of E. coli KS278 (⌬phoA) and Y. enterocolitica KNG22703 containing plasmid pRS8, -9, or -11 ( Table 2 ). All six extracts had high enzymatic activities, indicating that the PhoA moieties of the hybrid proteins were at least exported to the periplasm. VirG is thus an exported protein.
VirG is a lipoprotein. The signal sequence of VirG ends with Leu-Xaa-Gly-Cys, a motif which is characteristic of the processing site of lipoproteins (63) (Fig. 2) . Prolipoproteins are subjected to a cascade of modifications that give rise to mature lipoproteins having an N-terminal Cys residue modified by two fatty acyl groups through ester linkages and by a third fatty acyl group via an amide linkage (63) . These acylations can be detected after growth in the presence of radioactive palmitate. To verify whether VirG is indeed a lipoprotein, we labeled strain KNG22703 (pYV a Alkaline phosphatase activities in transformants of E. coli KS272 (⌬phoA) and Y. enterocolitica grown to stationary phase were assayed as described previously (30) . Values are means Ϯ standard deviations for three independent experiments. For each plasmid, the last amino acid of the VirG moiety of the hybrid PhoA is indicated. Plasmids pSF22 and pAA117 encode the Shigella flexneri hybrid lipoprotein MxiJ-PhoA and the recently reported Y. enterocolitica hybrid protein. YscU-PhoA, which expressed high and low alkaline phosphatase activities, respectively (1,2). ND, not detected; NT, not tested. 10 to 30 kDa were labeled, but there was no clear difference between the patterns of the two strains (data not shown). We then took advantage of the virG-phoA gene fusions described above because their larger size would allow easy detection. We assumed that the fused C-terminal PhoA moiety would not interfere with processing and addition of the acylation. Labeled proteins of approximately 53 kDa were detected in KNG22703 carrying plasmid pRS8, -9, or -11 (Fig. 4A , lanes 3 to 5) but not in the plasmidless host strain (Fig. 4A, lanes 1 and  2) . The size of those proteins is consistent with the size expected for the PhoA fusion proteins. From these results we concluded that VirG is a lipoprotein.
VirG is homologous to ExsB. The sequence of VirG was compared with the protein sequences in the GenBank library. This comparison revealed extensive similarity (26.2% identity in a 126-amino-acid overlap) between VirG and ExsB, a 137-amino acid Pseudomonas aeruginosa polypeptide encoded by a trans-regulatory locus controlling exoenzyme S (ExoS) synthesis (19) . The alignment (Fig. 5) shows the conservation of the Leu-Xaa-Gly-Cys motif in the amino-terminal part of ExsB (underlined), which suggests that ExsB is also a lipoprotein. The signal sequence of ExsB is very short, but the proposed start codon of ExsB is preceded by a possible GTG start codon (19) . The use of this upstream start codon made the alignment more complete and improved the signal sequence of ExsB by adding four amino acid residues, MRCW (indicated in boldface) (Fig. 5) . The size of ExsB could thus be revised. Interestingly, an even stronger similarity exists between the proteins encoded by the genes located downstream from virG and exsB, namely virF and exsA, respectively, as has been reported by Frank and Iglewski (19) . ExsA and VirF have 56% identity over their entire length, with their carboxy-terminal regions being almost identical. Both proteins belong to the AraC family of regulators.
Effect of the virG mutation on Yop synthesis and release. In order to investigate the role of VirG, we engineered a virG mutation in pYV227. The 210-bp EcoRI-BstEII fragment of pRS2 (from nucleotide 343 to 553) was replaced by the nonpolar aphA-3 cassette (31), giving pRS227 (see Materials and Methods and Fig. 1 ). Y. enterocolitica W22703(pRS227) was first tested for its capacity to produce and secrete the Yops. Upon thermal induction, the virG mutant secreted Yops. While no difference in YopH secretion was detected between wild-type and virG mutant strains, the amounts of the others Yops were reduced, especially those of YopB and YopD (Fig.  6, lanes 1 and 2, respectively) and LcrV (not visible in Fig. 6 ). The level of reduction of these Yops was quite variable from one experiment to another. Moreover, secretion of LcrV was more difficult to quantify in supernatants because of its higher solubility and possible losses during preparation. To ensure that the defect in Yop secretion was due to the virG mutation itself and not to a polar effect on the virF gene, we introduced pRS6 (Fig. 1) , a derivative of pTM100 containing only virG, into the mutant. Strain W22703(pRS227)(pRS6) was able to secrete Yops as well as the parental strain (Fig. 6, lane 3) . Thus, the defect resulted from the lack of the virG product. To decide whether the synthesis or secretion of YopB and YopD was compromised, we monitored the presence of YopD, YopE, and LcrV among the intracellular proteins by immunoblotting with monoclonal antibodies (Fig. 7) . YopD, YopE, and LcrV were detected in the virG mutant, and the signal was of approximately the same intensity as that observed in crude extracts of the wild-type strain (Fig. 7) . This result showed that export of these Yops is certainly affected. However, the fact that these Yops did not accumulate intracellularly indicates that their synthesis could also be reduced.
Effect of the virG mutation on growth restriction at 37 C in the absence of Ca
2؉
. Surprisingly, the virG mutant gave the same efficiency of plating at 37ЊC on MOX agar and on TSA. Hence, it was CI for growth at 37ЊC. The wild-type Ca plasmid pRS6 but not after introduction of pTM100, the vector used for the construction of pRS6 and derivatives (data not shown). The cloned virG gene complemented the mutation, confirming that the CI phenotype was exclusively due to the inactivation of the virG gene. To ensure that the ability to grow on MOX plates at 37ЊC was not the result of an increased frequency of loss of the pYV plasmid or mutations, we analyzed the plasmid profiles of six colonies recovered from MOX agar and six colonies isolated from TSA and grown at 37ЊC. We were unable to detect any difference in the plasmid contents and restriction profiles (not shown). Moreover, colonies isolated from MOX agar were used for trans-complementation experiments by introduction of pRS6. The transformants were unable to grow at 37ЊC on MOX medium and showed the same profile of secreted proteins as the wild-type strain. The virG mutant was thus phenotypically CI although it secreted Yops. Although Ca 2ϩ did not prevent growth of the virG mutant, it still prevented Yop secretion (data not shown). The virG mutant is thus not Ca 2ϩ blind. Site-directed mutagenesis of Cys-121 and Cys-125 of VirG. Cysteine residues are known to be involved in dimerization of some proteins by formation of disulfide bonds. Cysteines 121 and 125 are conserved among VirG and ExsB (Fig. 5) , suggesting that they may play a functional role in the VirG protein. To test this hypothesis, we replaced the codon for Cys-121 or Cys-125 with a serine codon on plasmid pRS7 and introduced both single mutations on the low-copy-number plasmid pRS6, giving rise to pRS6A (C121S) and pRS6B (C125S) (see Materials and Methods). pRS6A and pRS6B were then used to transform the virG mutant, and the phenotype of the virG mutant carrying either pRS6, pRS6A, or pRS6B was tested for Ca 2ϩ dependency and for Yop secretion. No difference in the phenotypes of these three strains was detected (data not shown), indicating that individual mutation of these cysteines does not influence the function of VirG, at least in our in vitro assays.
DISCUSSION
In the present study, we characterized virG, a new pYVrelated gene located immediately upstream of the virF gene. TnphoA mutagenesis generated three VirG-PhoA fusion proteins endowed with high levels of alkaline phosphatase activity, showing that VirG is at least exported to the periplasm. The presence of the motif Leu-Xaa-Gly-Cys at the end of the putative signal sequence of VirG suggested that VirG might be a lipoprotein (63) . Detection of VirG-PhoA fusion proteins after labeling with [ 3 H]palmitate confirmed that VirG is indeed a lipoprotein. Localization in the outer membrane of the Klebsiella pneumoniae lipoprotein pullulanase and of E. coli lipoproteins is dependent on the absence of an aspartate amino acid residue in position ϩ2, following the fatty acylated aminoterminal cysteine. Replacement of the serine residue (position ϩ2) by an aspartic acid directs hybrid lipo-␤-lactamase and pullulanase to fractionate with the inner membrane (21, 42, 45) . According to these observations, VirG, which contains an alanine residue in position ϩ2 of the mature protein and no charged amino acid residue between ϩ2 and ϩ5, is most likely located in the outer membrane.
To investigate the function of VirG, we generated a virG nonpolar mutation on the pYV plasmid and studied the phenotype of the resulting strain. The virG mutant secreted a smaller amount of Yops and was CI for growth at 37ЊC. The amounts of YopB, YopD, and LcrV were strongly reduced among the secreted Yops, but they could still be detected intracellularly (not tested for YopB). This phenotype could be complemented by the introduction of a plasmid harboring an intact copy of the virG gene into the mutant, confirming that this mutation resulted only in the lack of functional VirG.
If one judges from the phenotype, VirG does not seem primarily to regulate Yop production. The reduced release of YopD, YopB, and LcrV tends to suggest that VirG could be a nonessential component of the secretion machinery. The loss of the Ca 2ϩ requirement for growth, however, is impossible to interpret at this stage. First, it should be remembered that our virG mutants are not Ca 2ϩ blind like the yopN (17) and lcrG (51) mutants: although they have lost the Ca 2ϩ requirement for growth, they do not secrete Yops in the presence of Ca 2ϩ . This result is in agreement with the fact that YopN (LcrE), which has been reported to be a Ca 2ϩ sensor (17) , is secreted by the virG mutants. The present report is the first characterization of a CI mutant which still secretes Yops. This particular phenotype was previously described by Wolf-Watz et al. (62) for a Y. pseudotuberculosis mutant carrying an insertion in the same region of the pYV plasmid, but no gene was described in that early paper. One could hypothesize that VirG is an element of a regulatory pathway that determines growth arrest under low-Ca 2ϩ conditions. Alternatively, one could envision that the lack of a Ca 2ϩ requirement results from the poor secretion of YopB, YopD, and LcrV. However, since lcrV and yopBD polar mutants are not CI but are unable to grow at 37ЊC irrespective of the Ca 2ϩ concentration (4, 36, 44) , it is unlikely that the CI phenotype results simply from reduced secretion of YopB and YopD. Similarly, since nonpolar lcrV mutants are CI and unable to secrete Yops (43), one can also conclude that the phenotype does not result simply from reduced secretion of LcrV. Finally, one could hypothesize that reduced secretion of LcrV, YopB, and YopD could negatively influence the expression of another gene that is responsible for Ca 2ϩ dependency. We are thus still far from understanding the role of Ca 2ϩ in yersiniae. Here we simply add a new element of the puzzle.
VirG is similar to ExsB from P. aeruginosa. This similarity extends over the entire length of the proteins, which strongly suggests that they have similar localizations and functions. The motif Leu-Xaa-Gly-Cys is also present at the amino-terminal part of ExsB, which indicates that it could also be a lipoprotein. exsB is the second gene of an operon consisting of three genes, exsC, exsB, and exsA (64) . The three genes of the exs operon are referred to as a trans-regulatory locus required for ExoS synthesis (19, 20) . ExoS is an ADP-ribosyltransferase that plays a major role in the dissemination of P. aeruginosa from the initial colonization site in the skin to the bloodstream of infected animals (25, 37, 38) . The amino-terminal half of ExoS was recently shown to have 27% identity to YopE and to be controlled at the transcriptional level by ExsA (65) . The product of the gene (orfI) located just upstream of the exoS gene has 44% identity to SycE, the specific protein chaperone required for YopE secretion (65) . Like the Yops, ExoS is secreted without cleavage of an amino-terminal sequence (26) . Moreover, expression and secretion of ExoS are also induced by growing P. aeruginosa in a medium containing a Ca 2ϩ -chelating agent such as nitrilotriacetic acid or EDTA (65) . To summarize, VirG and ExsB are probably involved in the synthesis or secretion of virulence proteins. Their function remains to be determined. Type III secretion mechanism are now known to exist in various pathogenic bacteria, and the similarity in genetic organization and regulation of virG-virF and exsB-exsA as well as sycE-yopE and orf1-exoS indicates that such a secretion system is also present in P. aeruginosa. VOL. 177, 1995 virG OF YERSINIA ENTEROCOLITICA 4235
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